Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 40

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Human Natural Antibodies to Mammalian Carbohydrate Antigens as Unsung Heroes Protecting against Past, Present, and Future Viral Infections

Galili, Uri · 2020 · Antibodies

Abstract

Human natural antibodies to mammalian carbohydrate antigens (MCA) bind to carbohydrate-antigens synthesized in other mammalian species and protect against zoonotic virus infections. Three such anti-MCA antibodies are: (1) anti-Gal, also produced in Old-World monkeys and apes, binds to α-gal epitopes synthesized in non-primate mammals, lemurs, and New-World monkeys; (2) anti-Neu5Gc binds to Neu5Gc (N-glycolyl-neuraminic acid) synthesized in apes, Old-World monkeys, and many non-primate mammals; and (3) anti-Forssman binds to Forssman-antigen synthesized in various mammals. Anti-viral protection by anti-MCA antibodies is feasible because carbohydrate chains of virus envelopes are synthesized by host glycosylation machinery and thus are similar to those of their mammalian hosts. Analysis of MCA glycosyltransferase genes suggests that anti-Gal appeared in ancestral Old-World primates following catastrophic selection processes in which parental populations synthesizing α-gal epitopes were eliminated in enveloped virus epidemics. However, few mutated offspring in which the α1,3galactosyltransferase gene was accidentally inactivated produced natural anti-Gal that destroyed viruses presenting α-gal epitopes, thereby preventing extinction of mutated offspring. Similarly, few mutated hominin offspring that ceased to synthesize Neu5Gc produced anti-Neu5Gc, which destroyed viruses presenting Neu5Gc synthesized in parental hominin populations. A present-day example for few humans having mutations that prevent synthesis of a common carbohydrate antigen (produced in >99.99% of humans) is blood-group Bombay individuals with mutations inactivating H-transferase; thus, they cannot synthesize blood-group O (H-antigen) but produce anti-H antibody. Anti-MCA antibodies prevented past extinctions mediated by enveloped virus epidemics, presently protect against zoonotic-viruses, and may protect in future epidemics. Travelers to regions with endemic zoonotic viruses may benefit from vaccinations elevating protective anti-MCA antibody titers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/antib9020025

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 141

  1. Ochsenbein, 1999, Control of early viral and bacterial distribution and disease by natural antibodies, Science, 286, 2156, 10.1126/science.286.5447.2156 · DOI · Paper page
  2. Bovin, 2013, Natural antibodies to glycans, Biochemistry [Moscow], 78, 786, 10.1134/S0006297913070109 · DOI
  3. Blixt, 2004, Printed covalent glycan array for ligand profiling of diverse glycan binding proteins, Proc. Natl. Acad. Sci. USA, 101, 17033, 10.1073/pnas.0407902101 · DOI · Paper page
  4. Stowell, 2014, Microbial glycan microarrays define key features of host-microbial interactions, Nat. Chem. Biol., 10, 470, 10.1038/nchembio.1525 · DOI · Paper page
  5. Wiener, 1951, Origin of naturally occurring hemagglutinins and hemolysins; a review, J. Immunol., 66, 287, 10.4049/jimmunol.66.2.287 · doi:10.4049/jimmunol.66.2.287
  6. Springer, 1971, Blood-group and Forssman antigenic determinants shared between microbes and mammalian cells, Prog. Allergy, 15, 9
  7. Hooperm, 2010, Immune adaptation that maintain homeostasis with intestinal microbiota, Nat. Rev. Immunol., 10, 159, 10.1038/nri2710 · DOI · Paper page
  8. Watkins, 1980, Biochemistry and Genetics of the ABO, Lewis, and P blood group systems, Adv. Hum. Genet., 10, 379
  9. Galili, 1984, A unique natural human IgG antibody with anti-α-galactosyl specificity, J. Exp. Med., 160, 1519, 10.1084/jem.160.5.1519 · DOI · Paper page
  10. Hamadeh, 1995, Human secretions contain IgA, IgG and IgM anti-Gal [anti-α-galactosyl] antibodies, Clin. Diagn. Lab. Immunol., 2, 125, 10.1128/cdli.2.2.125-131.1995 · DOI
  11. McMorrow, 1997, Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal[α1,3]Galactose epitope, Transplantation, 64, 501, 10.1097/00007890-199708150-00021 · DOI
  12. Parker, 1999, Naturally occurring anti-α-galactosyl antibodies: Relationship to xenoreactive anti- α-galactosyl antibodies, Glycobiology, 9, 865, 10.1093/glycob/9.9.865 · DOI
  13. Galili, 1993, One percent of circulating B lymphocytes are capable of producing the natural anti-Gal antibody, Blood, 82, 2485, 10.1182/blood.V82.8.2485.2485 · DOI · Paper page
  14. Wang, 1995, Variations in activity of the human natural anti-Gal antibody in young and elderly populations, J. Gerontol. Med. Sci., 50A, M227, 10.1093/gerona/50A.4.M227 · doi:10.1093/gerona/50a.4.m227
  15. Galili, 1988, Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora, Infect. Immun., 56, 1730, 10.1128/iai.56.7.1730-1737.1988 · DOI · Paper page
  16. Posekany, 2002, Induction of cytolytic anti-Gal antibodies in α-1,3-galactosyltransferase gene knockout mice by oral inoculation with Escherichia coli O86:B7 bacteria, Infect. Immun., 70, 6215, 10.1128/IAI.70.11.6215-6222.2002 · DOI
  17. Blanco, 2001, Removal of bowel aerobic gram-negative bacteria is more effective than immunosuppression with cyclophosphamide and steroids to decrease natural α-galactosyl IgG antibodies, Xenotransplantation, 8, 15, 10.1034/j.1399-3089.2001.00082.x · DOI
  18. Galili, 1985, Human natural anti-α-galactosyl IgG. II. The specific recognition of α[1,3]-linked galactose residues, J. Exp. Med., 162, 573, 10.1084/jem.162.2.573 · DOI · Paper page
  19. Towbin, 1987, Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl [α1-3]-galactose epitopes, J. Exp. Med., 166, 419, 10.1084/jem.166.2.419 · DOI · Paper page
  20. Teneberg, 1996, Molecular mimicry in the recognition of glycosphingolipids by Galα3Galß4GlcNAcß-binding Clostridium difficile toxin A, human natural anti-α-galactosyl IgG and the monoclonal antibody Gal-13: Characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor, Glycobiology, 6, 599, 10.1093/glycob/6.6.599 · DOI
  21. Wang, 1995, Human anti-Gal heavy chain genes: Preferential use of VH3 and the presence of somatic mutations, J. Immunol., 155, 1276, 10.4049/jimmunol.155.3.1276 · DOI
  22. Galili, 1987, The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies, J. Exp. Med., 165, 693, 10.1084/jem.165.3.693 · DOI · Paper page
  23. Galili, 1987, Evolutionary relationship between the anti-Gal antibody and the Galα1-3Gal epitope in primates, Proc. Natl. Acad. Sci. USA, 84, 1369, 10.1073/pnas.84.5.1369 · DOI · Paper page
  24. Galili, 1988, Man, apes, and Old-World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells, J. Biol. Chem., 263, 17755, 10.1016/S0021-9258(19)77900-9 · DOI · Paper page
  25. Basu, 1973, Enzymatic synthesis of blood group related pentaglycosyl ceramide by an α-galactosyltransferase, J. Biol. Chem., 248, 1700, 10.1016/S0021-9258(19)44247-6 · DOI
  26. Larsen, 1990, Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:β-D-Gal[1,4]-D-GlcNAc α[1,3]-galactosyltransferase cDNA, J. Biol. Chem., 265, 7055, 10.1016/S0021-9258(19)39258-0 · DOI · Paper page
  27. Galili, 1991, Gene sequences suggest inactivation of α1-3 galactosyltransferase in catarrhines after the divergence of apes from monkeys, Proc. Natl. Acad. Sci. USA, 88, 7401, 10.1073/pnas.88.16.7401 · DOI · Paper page
  28. Koike, 2002, Molecular basis of evolutionary loss of the α1,3-galactosyltransferase gene in higher primates, J. Biol. Chem., 277, 10114, 10.1074/jbc.M110527200 · DOI
  29. Lanteri, 2002, A complete α1,3-galactosyltransferase gene is present in the human genome and partially transcribed, Glycobiology, 12, 785, 10.1093/glycob/cwf087 · DOI · Paper page
  30. Teranishi, 2002, Anti-Galα 1-3Gal IgM and IgG antibody levels in sera of humans and old world non-human primates, Xenotransplantation, 9, 148, 10.1034/j.1399-3089.2002.1o058.x · DOI
  31. Good, 1992, Identification of carbohydrate structures which bind human anti-porcine antibodies: Implication for discordant xenografting in man, Transplant. Proc., 24, 559
  32. Galili, 1993, Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: A major obstacle for xenotransplantation in humans, Immunol. Today, 14, 480, 10.1016/0167-5699(93)90261-I · DOI · Paper page
  33. Cooper, 1993, Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: Relevance to discordant xenografting in man, Transpl. Immunol., 1, 198, 10.1016/0966-3274(93)90047-C · DOI · Paper page
  34. Sandrin, 1993, Anti-pig IgM antibodies in human serum react predominantly with Gal (αl-3)Gal epitopes, Proc. Natl. Acad. Sci. USA, 90, 11391, 10.1073/pnas.90.23.11391 · DOI · Paper page
  35. Collins, 1995, Cardiac xenografts between primate species provide evidence for the importance of the α-galactosyl. determinant in hyperacute rejection, J. Immunol., 154, 5500, 10.4049/jimmunol.154.10.5500 · DOI · Paper page
  36. Xu, 1998, Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in-vivo by a Galα1-3Galβ1-4βGlc-X immunoaffinity column, Transplantation, 65, 172, 10.1097/00007890-199801270-00005 · DOI · Paper page
  37. Shaw, 1988, The biosynthesis of N-glycoloylneuraminic acid occurs by hydroxylation of the CMP-glycoside of N-acetylneuraminic acid, Biol. Chem. Hoppe. Seyler, 369, 477, 10.1515/bchm3.1988.369.1.477 · DOI
  38. Muchmore, 1998, A structural difference between the cell surfaces of humans and the great apes, Am. J. Phys. Anthropol., 107, 187, 10.1002/(SICI)1096-8644(199810)107:2<187::AID-AJPA5>3.0.CO;2-S · doi:10.1002/(sici)1096-8644(199810)107:2<187::aid-ajpa5>3.0.co;2-s
  39. Gagneux, 1999, Evolutionary considerations in relating oligosaccharide diversity to biological function, Glycobiology, 9, 747, 10.1093/glycob/9.8.747 · DOI · Paper page
  40. Varki, 2010, Colloquium paper: Uniquely human evolution of sialic acid genetics and biology, Proc. Natl. Acad. Sci. USA, 107, 8939, 10.1073/pnas.0914634107 · DOI · Paper page
  41. Chou, 1998, A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence, Proc. Natl. Acad. Sci. USA, 95, 11751, 10.1073/pnas.95.20.11751 · DOI · Paper page
  42. Irie, 1998, The molecular basis for the absence of N-glycolylneuraminic acid in humans, J. Biol. Chem., 273, 15866, 10.1074/jbc.273.25.15866 · DOI · Paper page
  43. Merrick, 1978, Characterization of the Hanganutziu-Deicher [serum-sickness] antigen as gangliosides containing N-glycolylneuraminic acid, Int. Arch. Allergy Appl. Immunol., 57, 477, 10.1159/000232140 · DOI
  44. Zhu, 2002, Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum, Xenotransplantation, 9, 376, 10.1034/j.1399-3089.2002.02138.x · DOI · Paper page
  45. Yu, 2008, Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for disease, Glycobiology, 18, 818, 10.1093/glycob/cwn072 · DOI · Paper page
  46. Tahara, 2010, Immunological property of antibodies against N-glycolylneuraminic acid epitopes in cytidine monophospho-N-acetylneuraminic acid hydroxylase-deficient mice, J. Immunol., 184, 3269, 10.4049/jimmunol.0902857 · DOI
  47. Nguyen, 2005, Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells, J. Immunol., 175, 228, 10.4049/jimmunol.175.1.228 · DOI
  48. Young, 1979, Characterization of anti-Forssman [anti-Fs] antibodies in human sera: Their specificity and possible changes in patients with cancer, J. Immunol., 123, 92, 10.4049/jimmunol.123.1.92 · DOI
  49. Takahashi, 1981, Anti-Forssman antibody in human sera: Properties and decreased level in cancer patients, Jpn. J. Exp. Med., 51, 149
  50. Siddiqui, 1971, A revised structure for the Forssman glycolipid hapten, J. Biol. Chem., 246, 5766, 10.1016/S0021-9258(18)61871-X · doi:10.1016/s0021-9258(18)61871-x
  51. Das, 1986, Biosynthesis in vitro of a globoside containing a 2-acetamido-2-deoxy-beta-D-galactopyranosyl group [1-.3]- linked and Forssman glycolipid by two N-acetylgalactosaminyltransferases from chemically transformed guinea pig cells, Carbohydr. Res., 149, 119, 10.1016/S0008-6215(00)90373-2 · doi:10.1016/s0008-6215(00)90373-2
  52. Haslam, 1996, Expression cloning of Forssman glycolipid synthetase: A novel member of the histo-blood group ABO gene family, Proc. Natl. Acad. Sci. USA, 93, 10697, 10.1073/pnas.93.20.10697 · DOI
  53. Narasimhan, 1978, Comparative study of the glycosphingolipids of chicken bursa of Fabricius and of chicken, rat and human thymus, Biochem. J., 173, 475, 10.1042/bj1730475 · doi:10.1042/bj1730475
  54. Breimer, 1981, Blood group type glycosphingolipids from the small intestine of different animals analyzed by mass spectrometry and thin-layer chromatography. A note on species diversity, J. Biochem., 90, 589, 10.1093/oxfordjournals.jbchem.a133513 · DOI
  55. Yamamoto, 2012, Molecular genetic basis of the human Forssman glycolipid antigen negativity, Sci. Rep., 2, 975, 10.1038/srep00975 · DOI
  56. Jesus, 2018, Prevalence of antibodies to a new histo-blood system: The FORS system, Blood Transfus., 16, 178
  57. Varki, A., Cummings, R.D., and Esko, J.D. (2019, March 15). Glycosyltransferases and Glycan-Processing Enzymes [Chapter 6], Essentials of Glycobiology [Internet], Available online: https://www.ncbi.nlm.nih.gov/books/NBK310274/.
  58. Repik, 1994, Differential host dependent expression of α-galactosyl epitopes on viral glycoproteins: A study of Eastern equine encephalitis virus as a model, J. Gen. Virol., 75, 1177, 10.1099/0022-1317-75-5-1177 · DOI
  59. Galili, 1996, Enhancement of antigen presentation of influenza virus hemagglutinin by the natural anti-Gal antibody, Vaccine, 14, 321, 10.1016/0264-410X(95)00189-8 · DOI
  60. Pipperger, 2019, Xenoantigen-dependent complement-mediated neutralization of LCMV glycoprotein pseudotyped VSV in human serum, J. Virol., 93, e00567-19, 10.1128/JVI.00567-19 · DOI
  61. Smith, 1990, Transfer and expression of a murine UDP-Gal:β-D-Gal-α1,3-galactosyltransferase gene in transfected Chinese hamster ovary cells. Competition reactions between the α1,3-galactosyltransferase and the endogenous α2,3-sialyltransferase, J. Biol. Chem., 265, 6225, 10.1016/S0021-9258(19)39314-7 · DOI
  62. Taatjes, 1987, Distribution of galactosyl- and sialyltransferase: Reorganization of trans Golgi apparatus elements in hepatocytes in intact liver and cell culture, Eur. J. Cell Biol., 44, 187
  63. Henion, 1997, Synthesis of α-gal epitopes on influenza virus vaccines, by recombinant α1,3galactosyltransferase, enables the formation of immune complexes with the natural anti-Gal antibody, Vaccine, 15, 1174, 10.1016/S0264-410X(96)00300-3 · DOI
  64. Rother, 1995, A novel mechanism of retrovirus inactivation in human serum mediated by anti-α-galactosyl natural antibody, J. Exp. Med., 182, 1345, 10.1084/jem.182.5.1345 · DOI · Paper page
  65. Takeuchi, 1996, Sensitization of cells and retroviruses to human serum by [α1-3] galactosyltransferase, Nature, 379, 85, 10.1038/379085a0 · DOI · Paper page
  66. Patience, 1997, Infection of human cells by an endogenous retrovirus of pigs, Nat. Med., 3, 282, 10.1038/nm0397-282 · DOI · Paper page
  67. Takeuchi, 1997, Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(α1-3)galactosylation, J. Virol., 71, 6174, 10.1128/jvi.71.8.6174-6178.1997 · DOI
  68. Welsh, 1998, Evaluation of the Galα1-3Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses, J. Virol., 72, 4650, 10.1128/JVI.72.6.4650-4656.1998 · DOI
  69. Hayashi, 2004, The neutralization of pseudorabies virus by anti-α-galactocyl natural antibody in normal serum, Virus Res., 99, 1, 10.1016/j.virusres.2003.09.008 · DOI
  70. Preece, 2002, Expression of ABO or related antigenic carbohydrates on viral envelopes leads to neutralization in the presence of serum containing specific natural antibodies and complement, Blood, 99, 2477, 10.1182/blood.V99.7.2477 · DOI · Paper page
  71. Baple, 2007, Virus recognition by specific natural antibodies and complement results in MHC I cross-presentation, J. Immunol., 37, 1254
  72. Kim, 2007, Natural protection from zoonosis by α-gal epitopes on virus particles in xenotransmission, Xenotransplantation, 14, 104, 10.1111/j.1399-3089.2007.00377.x · DOI
  73. Cheng, 2005, ABO blood group and susceptibility to severe acute respiratory syndrome, JAMA, 293, 1450
  74. Guillon, 2008, Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies, Glycobiology, 18, 1085, 10.1093/glycob/cwn093 · DOI · Paper page
  75. Paradis, 1999, Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group, Science, 285, 1236, 10.1126/science.285.5431.1236 · DOI · Paper page
  76. Houston, 1977, Inactivated Venezuelan equine encephalomyelitis virus vaccine complexed with specific antibody: Enhanced primary immune response and altered pattern of antibody class elicited, J. Infect. Dis., 135, 600, 10.1093/infdis/135.4.600 · doi:10.1093/infdis/135.4.600
  77. Villinger, 2003, Evidence for antibody-mediated enhancement of simian immunodeficiency virus [SIV] Gag antigen processing and cross presentation in SIV-infected rhesus macaques, J. Virol., 77, 10, 10.1128/JVI.77.1.10-24.2003 · DOI
  78. Wen, 1999, Antigen-antibody complex as therapeutic vaccine for viral hepatitis B, Int. Rev. Immunol., 18, 251, 10.3109/08830189909043028 · doi:10.3109/08830189909043028
  79. Wigglesworth, 2009, Mechanism for increased immunogenicity of vaccines that form in-vivo immune complexes with the natural anti-Gal antibody, Vaccine, 27, 3072, 10.1016/j.vaccine.2009.03.019 · DOI
  80. Guay, 2007, Increased immunogenicity of influenza virus vaccine by anti-Gal mediated targeting to antigen presenting cells, J. Virol., 81, 9131, 10.1128/JVI.00647-07 · DOI
  81. Wang, 2006, Increased Immunogenicity of Human Immunodeficiency Virus gp120 Engineered to Express Galα1-3Galβ1-4GlcNAc-R Epitopes, J. Virol., 80, 6943, 10.1128/JVI.00310-06 · DOI
  82. Wang, 2010, Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing α-gal epitopes, Vaccine, 28, 1758, 10.1016/j.vaccine.2009.12.015 · DOI
  83. Benatuil, 2005, The influence of natural antibody specificity on antigen immunogenicity, Eur. J. Immunol., 35, 2638, 10.1002/eji.200526146 · DOI
  84. Galili, 2007, Intratumoral injection of α-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines, J. Immunol., 178, 4676, 10.4049/jimmunol.178.7.4676 · DOI
  85. Buonomano, 1999, Quantitation and characterization of anti-Galα1-3Gal antibodies in sera of 200 healthy persons, Xenotransplantation, 6, 173, 10.1034/j.1399-3089.1999.00023.x · DOI
  86. Maruyama, 1999, Interaction of baboon anti-α-galactosyl antibody with pig tissues, Am. J. Pathol., 155, 1635, 10.1016/S0002-9440(10)65479-X · DOI
  87. Galili, U. (2018). The Natural Anti-Gal Antibody as Foe Turned Friend in Medicine, Elsevier, Academic Press.
  88. Galili, 1995, Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters, Transplantation, 59, 1549, 10.1097/00007890-199506150-00008 · DOI
  89. Almeida, 1991, Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-α-galactosyl antibodies, J. Immunol., 146, 2394, 10.4049/jimmunol.146.7.2394 · DOI
  90. Almeida, 1994, Lytic anti-α-galactosyl antibodies from patients with chronic Chagas’ disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi, Biochem. J., 304, 793, 10.1042/bj3040793 · DOI · Paper page
  91. Ramasamy, 1987, Terminal galactose residues and the antigenicity of Plasmodium falciparum glycoproteins, J. Clin. Microbiol., 25, 2075
  92. Ravindran, 1988, Naturally-occurring anti-α-galactosyl antibodies in human Plasmodium falciparum infections: A possible role for autoantibodies in malaria, Immunol. Lett., 19, 137, 10.1016/0165-2478(88)90133-2 · DOI
  93. Ramasamy, 1997, Association of malaria with inactivation of α1,3-galactosyl transferase in catarrhines, Biochim. Biophys. Acta, 1360, 241, 10.1016/S0925-4439(97)00005-7 · doi:10.1016/s0925-4439(97)00005-7
  94. Yilmaz, 2014, Gut microbiota elicits a protective immune response against malaria transmission, Cell, 159, 1277, 10.1016/j.cell.2014.10.053 · DOI · Paper page
  95. Alberdi, 2017, Effect of blood type on anti-α-Gal immunity and the incidence of infectious diseases, Exp. Mol. Med., 10, e301
  96. Groth, 1994, Transplantation of fetal porcine pancreas to diabetic patients: Biochemical and histological evidence for graft survival, Lancet, 344, 1402, 10.1016/S0140-6736(94)90570-3 · DOI · Paper page
  97. Whalen, 2012, Cancer Immunotherapy by intratumoral injection of α-gal glycolipids, Anticancer Res., 32, 3861
  98. Konakci, 2005, α-gal on bioprostheses: Xenograft immune response in cardiac surgery, Eur. J. Clin. Investig., 35, 17, 10.1111/j.1365-2362.2005.01441.x · DOI · Paper page
  99. Böer, U., Buettner, F.F.R., Schridde, A., Klingenberg, M., Sarikouch, S., Haverich, A., and Wilhelmi, M. (2017). Antibody formation towards porcine tissue in patients implanted with crosslinked heart valves is directed to antigenic tissue proteins and αGal epitopes and is reduced in healthy vegetarian subjects. Xenotransplantation, 24. · DOI
  100. Stone, 2007, Replacement of human anterior cruciate ligament with pig ligament: A model for anti-non gal antibody response in long-term xenotransplantation, Transplantation, 83, 211, 10.1097/01.tp.0000250598.29377.13 · DOI
  101. Feldmann, 1994, Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein, Virology, 199, 469, 10.1006/viro.1994.1147 · doi:10.1006/viro.1994.1147
  102. Commins, 2013, Tick bites and red meat allergy, Curr. Opin. Allergy Clin. Immunol., 13, 354, 10.1097/ACI.0b013e3283624560 · DOI
  103. Wilson, 2019, Investigation into the α-Gal Syndrome: Characteristics of 261 Children and Adults Reporting Red Meat Allergy, J. Allergy. Clin. Immunol. Pract., 7, 2348, 10.1016/j.jaip.2019.03.031 · DOI · Paper page
  104. Schrago, 2013, Combining fossil and molecular data to date the diversification of New World primates, J. Evol. Biol., 26, 2438, 10.1111/jeb.12237 · DOI
  105. Larsen, 1989, Isolation of a cDNA encoding murine UDP galactose: ßD-galactosyl-1,4-N-acetyl-D-glucosaminide α1,3-galactosyltransferase: Expression cloning by gene transfer, Proc. Natl. Acad. Sci. USA, 86, 8227, 10.1073/pnas.86.21.8227 · DOI · Paper page
  106. Joziasse, 1989, Bovine α1-3galactosyltransferase: Isolation and characterization of a cDNA clone. Identification of homologous sequences in human genomic DNA, J. Biol. Chem., 264, 14290, 10.1016/S0021-9258(18)71676-1 · DOI · Paper page
  107. Henion, 1994, Defining the minimal size of catalytically active primate α1,3galactosyltransferase: Structure function studies on the recombinant truncated enzyme, Glycobiology, 4, 193, 10.1093/glycob/4.2.193 · DOI
  108. Miller, 2009, Systematics of early and middle Miocene Old World monkeys, J. Hum. Evol., 57, 195, 10.1016/j.jhevol.2009.06.006 · DOI
  109. Lewis, 1962, Catastrophic selection as a factor in speciation, Evolution, 16, 257, 10.2307/2406275 · DOI
  110. Lai, 2002, Production of α-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning, Science, 295, 1089, 10.1126/science.1068228 · DOI · Paper page
  111. Phelps, 2003, Production of α1,3-galactosyltransferase-deficient pigs, Science, 299, 411, 10.1126/science.1078942 · DOI · Paper page
  112. Dor, 2004, α1,3-Galactosyltransferase gene-knockout miniature swine produce natural cytotoxic anti-Gal antibodies, Transplantation, 78, 15, 10.1097/01.TP.0000130487.68051.EB · DOI
  113. Fang, 2012, Anti-gal antibodies in α1,3-galactosyltransferase gene knockout pigs, Xenotransplantation, 19, 305, 10.1111/j.1399-3089.2012.00710.x · DOI
  114. Galili, 2013, α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates, Xenotransplantation, 20, 267, 10.1111/xen.12051 · DOI
  115. Bhende, 1952, A new blood group character related to the ABO system, Lancet, 1, 903
  116. Bhatia, 1974, Incidence of Bombay Oh phenotype and weaker variants of A and B antigens in Bombay (India), Vox Sang., 27, 524, 10.1111/j.1423-0410.1974.tb02450.x · doi:10.1111/j.1423-0410.1974.tb02450.x
  117. Gerard, 1982, H-deficient blood groups (Bombay) of Réunion Island, Am. J. Hum. Genet., 34, 937
  118. Mulet, 1977, Activity of 2-α-Lfucosyltransferase in human sera and red cell membranes. Study of common ABH blood donors, rare ‘Bombay’ and ‘Parabombay’ individuals, FEBS Lett., 84, 74, 10.1016/0014-5793(77)81060-0 · doi:10.1016/0014-5793(77)81060-0
  119. Cartron, 1983, H-deficient blood groups of Reunion Island. III. α-2-Lfucosyltransferase activity in sera of homozygous and heterozygous individuals, Am. J. Hum. Genet., 35, 497
  120. Balgir, 2005, Detection of a rare blood group “Bombay (Oh) Phenotype” among the Kutia Kondh primitive tribe of Orissa, India, Int. J. Hum. Genet., 5, 193, 10.1080/09723757.2005.11885925 · doi:10.1080/09723757.2005.11885925
  121. Gerl, 2012, Quantitative analysis of the lipidomes of the influenza virus envelope and MDCK cell apical membrane, J. Cell. Biol., 196, 213, 10.1083/jcb.201108175 · DOI · Paper page
  122. Campbell, 2014, Humoral response to a viral glycan correlates with survival on PROSTVAC-VF, Proc. Natl. Acad. Sci. USA, 111, E1749, 10.1073/pnas.1314722111 · DOI
  123. Yeh, 2010, Investigation of potential carbohydrate antigen targets for human and baboon antibodies, Xenotransplantation, 17, 197, 10.1111/j.1399-3089.2010.00579.x · DOI
  124. Briles, 1975, Physiological studies on the pneumococcal Forssman antigen: A choline-containing lipoteichoic acid, J. Gen. Microbiol., 86, 267, 10.1099/00221287-86-2-267 · doi:10.1099/00221287-86-2-267
  125. Ostrander, 1988, Isolation and characterization of the major acidic glycosphingolipids from the liver of the English sole (Parophrys vetulus). Presence of a novel ganglioside with a Forssman antigen determinant, J. Biol. Chem., 263, 3103, 10.1016/S0021-9258(18)69041-6 · doi:10.1016/s0021-9258(18)69041-6
  126. Bouhours, 1999, Forssman penta- and tetraglycosylceramide are xenoantigens of ostrich kidney and liver, Glycobiology, 9, 875, 10.1093/glycob/9.9.875 · doi:10.1093/glycob/9.9.875
  127. Kawsar, 2009, Glycan-binding profile and cell adhesion activity of American bullfrog [Rana catesbeiana] oocyte galectin-1, Protein Pept. Lett., 16, 677, 10.2174/092986609788490104 · DOI
  128. Larsen, 1990, Molecular cloning, sequence, and expression of a human GDP-L-fucose:β-Dgalactoside 2-α-L-fucosyltransferase cDNA that can form the H blood group antigen, Proc. Natl. Acad. Sci. USA, 87, 6674, 10.1073/pnas.87.17.6674 · doi:10.1073/pnas.87.17.6674
  129. Kelly, 1994, Molecular basis for H blood group deficiency in Bombay (Oh) and para-Bombay individuals, Proc. Natl. Acad. Sci. USA, 91, 5843, 10.1073/pnas.91.13.5843 · DOI · Paper page
  130. Kaneko, 1997, Wide variety of point mutations in the H gene of Bombay and para-Bombay individuals that inactivate H enzyme, Blood, 90, 839, 10.1182/blood.V90.2.839 · DOI
  131. Koda, 1997, Missense mutation of FUT1 and deletion of FUT2 are responsible for Indian Bombay phenotype of ABO blood group system, Biochem. Biophys. Res. Commun., 238, 21, 10.1006/bbrc.1997.7232 · DOI
  132. Wagner, 1997, Polymorphism of the h allele and the population frequency of sporadic nonfunctional alleles, Transfusion, 37, 284, 10.1046/j.1537-2995.1997.37397240210.x · DOI
  133. Oriol, 2000, Molecular genetics of H, Vox Sang., 78, 105
  134. Storry, 2006, Identification of six new alleles at the FUT1 and FUT2 loci in ethnically diverse individual s with Bombay and ParaBombay phenotypes, Transfusion, 46, 2149, 10.1111/j.1537-2995.2006.01045.x · doi:10.1111/j.1537-2995.2006.01045.x
  135. Dipta, 2011, The Bombay blood group: Are we out of risk?, Mymensingh Med. J., 20, 536
  136. Malhotra, 2014, Acute hemolytic transfusion reaction in a patient with Bombay phenotype: Implications for ABO grouping, Indian J. Hematol. Blood Transfus., 30, 108, 10.1007/s12288-013-0277-9 · doi:10.1007/s12288-013-0277-9
  137. Agarwal, 2016, Managing rare blood group requests—Bombay oh phenotype: Our experience with www.bombaybloodgroup.org, Blood Transfus., 14, 89
  138. Seymour, 2004, Evolution of the human ABO polymorphism by two complementary selective pressures, Proc. Biol. Sci., 271, 1065, 10.1098/rspb.2004.2674 · DOI
  139. Neil, 2005, HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation, Blood, 105, 4693, 10.1182/blood-2004-11-4267 · DOI
  140. Aho, 1980, ABO associated genetic determinant in H1N1 influenza, Tissue Antigens, 16, 310, 10.1111/j.1399-0039.1980.tb00311.x · doi:10.1111/j.1399-0039.1980.tb00311.x
  141. Naikhin, 1989, Indicators of collective immunity to influenza depending on the blood group and sex of the population, Voprosy Virusologii, 34, 419

Cited by

See all 40

Metadata

Authors
Galili, U.
Affiliations
Department of Medicine, Rush University Medical School, Chicago, IL 60605, USA
Venue
Antibodies
Publisher
MDPI AG
Published
2020-06-22
Volume
9
Issue
2
Pages
25
ISSN
2073-4468
Cited by
40
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.